Understanding Low AMH & Diminished Ovarian Reserve
Receiving a diagnosis of low AMH or diminished ovarian reserve can feel like one of the most discouraging moments in a fertility journey. Many patients are told their options are limited and that conception with their own eggs may not be realistic. However the landscape of reproductive medicine is evolving rapidly and there are now more meaningful pathways available than ever before for women facing these specific challenges.
Low AMH fertility options today extend well beyond the standard advice of moving directly to donor eggs or abandoning treatment altogether. Regenerative approaches including Platelet-Rich Plasma ovarian therapy are increasingly being explored as a way to stimulate dormant follicles, improve ovarian blood flow, and encourage the development of healthier eggs in women whose ovarian reserve has declined significantly.
Similarly diminished ovarian reserve options have expanded to include highly individualized IVF stimulation protocols, targeted nutritional and lifestyle interventions, and regenerative therapies that work alongside conventional treatment rather than replacing it entirely.
Understanding that a low AMH result is not a final verdict but rather a starting point for a more targeted and personalized conversation with a reproductive specialist is the most important shift any patient can make.
